Rotavirus vaccines - an update

被引:14
作者
Kirkwood, CD
Buttery, J
机构
[1] Univ Melbourne, Enteric Virus Res Grp, Dept Gastroenterol & Clin Nutr,Dept Paediat, Murdoch Childrens Res Inst,Royal Childrens Hosp, Parkville, Vic 3052, Australia
[2] Royal Childrens Hosp, Clin Paediat Infect Dis Unit, Parkville, Vic 3052, Australia
关键词
immunisation; rotavirus; rotavirus vaccine; vaccine;
D O I
10.1517/14712598.3.1.97
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rotavirus vaccines offer the best hope to reduce the toll of acute rotaviral gastroenteritis in both developed and developing countries. An association with intussusception (IS) led to the withdrawal of the first licensed rotavirus vaccine in the USA in 1999, forcing a re-evaluation of the safety profile of potentially lifesaving vaccines. Development of new rotavirus vaccine candidates has continued, with a bovine-human reassortant vaccine and an attenuated human monovalent vaccine commencing Phase III trials. Several other candidates are in early Phase I and II clinical trials. The creation of innovative funding strategies to support vaccine development and production, specifically in developing countries, aim to make vaccines available where rotavirus causes the greatest impact.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 100 条
  • [91] Hospital admissions attributable to rotavirus infection in England and Wales
    Ryan, MJ
    Ramsay, M
    Brown, D
    Gay, NJ
    Farrington, CP
    Wall, PG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 : S12 - S18
  • [92] Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins
    Schwartz-Cornil, I
    Benureau, Y
    Greenberg, H
    Hendrickson, BA
    Cohen, J
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (16) : 8110 - 8117
  • [93] STEELE AD, 2002, 2 M MEMB AS ROT SURV
  • [94] SURVEY OF ROTAVIRUS G-TYPE AND P-TYPE ASSOCIATED WITH HUMAN GASTROENTERITIS IN SAO-PAULO, BRAZIL, FROM 1986 TO 1992
    TIMENETSKY, MDST
    SANTOS, N
    GOUVEA, V
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2622 - 2624
  • [95] Cost-effectiveness analysis of a rotavirus immunization program for the United States
    Tucker, AW
    Haddix, AC
    Bresee, JS
    Holman, RC
    Parashar, UD
    Glass, RI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (17): : 1371 - 1376
  • [96] Evidence of high-frequency genomic reassortment of group a rotavirus strains in Bangladesh: Emergence of type G9 in 1995
    Unicomb, LE
    Podder, G
    Gentsch, JR
    Woods, PA
    Hasan, KZ
    Faruque, ASG
    Albert, MJ
    Glass, RI
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 1885 - 1891
  • [97] Rotavirus infection in infants as protection against subsequent infections
    Velazquez, FR
    Matson, DO
    Calva, JJ
    Guerrero, ML
    Morrow, AL
    CarterCampbell, S
    Glass, RI
    Estes, MK
    Pickering, LK
    RuizPalacios, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1022 - 1028
  • [98] Mechanisms of protection against rotavirus in humans and mice
    Ward, RL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 : S51 - S58
  • [99] Zhou YM, 2001, J MED VIROL, V65, P619, DOI 10.1002/jmv.2081
  • [100] 1999, MMWR, V48, P1007